News/ News/ Oncology RedX Pharma CEO focuses on pipeline that found Lilly’s rising star Richard Staines Oncology, pancreatic cancer, R&D, Redx Pharma 0 Comment Back in 2017, the UK biotech RedX Pharma had to sell its prized asset after administrators stepped in Share X RedX Pharma CEO focuses on pipeline that found Lilly’s rising star https://pharmaphorum.com/news/redx-looks-to-keep-pipeline-assets-after/
News/ News/ R&D/ Top stories Redx shares soar after IPF drug licence deal with AstraZeneca Richard Staines AstraZeneca, Boehringer Ingelheim, idiopathic pulmonary fibrosis, IPF, R&D, Redx Pharma, respiratory diseases, Roche 0 Comment Shares in Redx Pharma were soaring this morning after it licensed its preclinical fibrotic disease drug RXC006 to Share X Redx shares soar after IPF drug licence deal with AstraZeneca https://pharmaphorum.com/news/redx-shares-soar-after-ipf-drug-deal-with-astrazeneca/
